2018 Speakers






  • Susan Solomon , CEO and Co-Founder, New York Stem Cell Foundation
  • Sven Kili, Vice President & Head, Gene Therapy Development, GSK
  • Eric Soller , Vice President of Corporate Development & Strategy, BlueRock Therapeutics
  • Margo Roberts , CSO, Kite Pharma
  • Sue Hill , Chief Scientific Officer, NHS
  • Brad Perkins , Chief Medical Officer, Human Longevity
  • Julia Wilson , Associate Director, Wellcome Trust Sanger Institute
  • Paul P. Tak , Academic Medical Centre, University of Amsterdam;  Senior Vice President of Research & Development Pipeline, Chief Immunology Officer, GSK
  • Ian Abbs , Chief Medical Officer, Guys’ and St. Thomas’ NHS Foundation Trust
  • Milind Kamjolar , Chief Data Officer, Sanofi
  • Patrick Keohane , Chief Medical Officer, BenevolentAI
  • Juergen Hammer , Global Head, Data Science, Roche
  • Nivan Narain , Co-founder and CEO, Berg
  • Elizabeth Shpall , Director, MD Anderson Cancer Center
  • Joanne Kurtzberg , Director, Carolinas Cord Blood Bank, Duke University
  • Todd McAllister , Executive Director, Amnion Foundation
  • Colleen Delaney , Founder and Chief Medical Officer, Nohla Therapeutics

Advanced Therapies & Regenerative Medicine:

Ajan Reginald , Chief Executive Officer, Celixir

Alain Vertès , Managing Director, NxR Biotechnologies

Alex Pemberton , Programme Manager UKRMP, Medical Research Council

André Choulika , Chairman & Chief Executive Officer, Cellectis

Andrea Piccin, Consultant Haematologist , Haematology Dept & BMT Unit, San Maurizio Regional Hospital Bolzano
Bob Harman
, CEO, VetStem Biopharma, Inc.

Benjamin Shepherd , Director, Therapeutics, Organovo

Chaim Lebovits , CEO, Brainstorm Cell Therapeutics

Christoph Neyer , ‎Director Business Development, InGeneron GmbH

Claudia Mitchell , CEO, Universal Cells, Inc.

Damien Bates , Chief Medical Officer & Head of Research, SanBio

David Pettitt , Research Associate, Centre for the Advancement of Sustainable Medical Innovation (CASMI), DPhil Candidate, Medical Sciences, University of Oxford

Didier Caizergues , Head of Regulatory Affairs Department, Genethon

Diego Ardigò , Project Lead, Chiesi Group

Eduardo Bravo , Managing Director and CEO, TiGenix

Eric Soller , Vice President of Corporate Development & Strategy, BlueRock Therapeutics

Gerry Graham , Head, Chemokine Research Group & Deputy Head of the Institute of Infection, Immunity and Inflammation, University of Glasgow 

Giovanna Lombardi , Professor, Human Transplant Immunology, Transplantation Immunology & Mucosal Biology, MRC Centre for Transplantation, King’s College London (KCL)

Giulia Detela , Process Design Manager, VivaBioCell S.p.A.

Giuseppe Mazza , Chief Executive & Scientific Officer, Engitix 

Ian Campbell , Director for Health and Life Sciences, Innovate UK 

James Miskin , Chief Technical Officer, Oxford BioMedica

James Noble , CEO, Adaptimmune

Jane Lebkowski , ‎President of R&D, Asterias Biotherapeutics

Jeff Abbey , CEO, Argos Therapeutics

Jeffrey Schaffer , Director of Veterinary Professional Services, VetStem

John Campbell , Associate Director, Research, Development & Innovation, SNBTS, National Science Laboratory

John Tchelingerian , CEO, Promethera, Biosciences

Katy Spink , Chief Operating Officer, Asterias Biotherapeutics

Kristin Comella , Chief Science Officer, US Stem Cell Inc.

Marc Turner , Medical Director, SNBTS

Margo Roberts , CSO, Kite Pharma

Mark Zimmerman , Vice President, Business Development and Strategy, ViaCyte

Mehis Pilv , Cofounder and Managing Director, GeneCode Ltd

Michael Stein , Chairman & CEO, Oxstem

Michael West , CEO, BioTime; CEO , AgeX Therapeutics

Michele Lipucci , CAT Full Member, Patients’ representative, EMA

Nick Crabb , Programme Director – Scientific Affairs, NICE

Norio Nakatsuji, Founding Director , Institute for Integrated Cell-Material Sciences (iCeMS), Kyoto University, Kyoto, Japan

Ohad Karnieli , Chair, Process and Product Development Subcommittee, ISCT ; CEO & Co-Founder, ATVIO 

Pascale V Guillot , Head of the Cellular Reprogramming & Perinatal Therapy Team, Institute for Women’s Health UCL

Paul Peter Tak , Professor of Medicine, Rheumatology, Academic Medical Center, University of Amsterdam AMC (Senior Vice President of Research and Development Pipeline and Chief Immunology Officer, GSK & Board Member, Galvani )

Peder Olofsson , Leader, Center for Bioelectronic Medicine, Department of Medicine, Karolinska Institutet

Qasim Rafiq , Senior Lecturer in Bioprocessing of Regenerative, Cellular and Gene Therapy, UCL

Roger Smith , Professor, Equine Orthopaedics, Royal Veterinary College (RVC)

Stephen Badylak , Professor, Department of Surgery, Deputy Director of the McGowan Institute for Regenerative Medicine (MIRM), & Director, Center for Pre-Clinical Tissue Engineering within the Institute

Susan Solomon , CEO and Co-Founder, New York Stem Cell Foundation

Suzanne S. Farid , Professor of Bioprocess Systems Engineering, UCL

Todd McAllister , Executive Director, Amnion Foundation

Václav Procházka , Deputy Director for Science & Research, University Hospital Ostrava

Yen Choo , CEO, Progenitor Therapeutics

Zami Aberman , Chairman & CEO, Pluristem Therapeutics

Representative from Cellgenix

Representative from ThermoFisher

Representative from Cryoport

Representative from Terumo

Representative from Fujifilm Diosynth

Representative from Maxcyte

Representative from Merck

Representative from Novo Nordisk Pharmatech

Representative from PCT Cell Therapy Services





Ajoy Velayudhan

Alessandro Butte , Senior Researcher, ETH Group

Berthold Boedeker , Chief Scientist, Global Drug Discovery – Global Biologics Biotech Development, Bayer AG

Charles Haynes , Chemical & Biological Engineering, University of British Columbia

Christoph Herwig , Professor of Biochemical Engineering, Vienna University of Technology ; Founder & Scientific Advisor, Exputec

Cornelia Kasper , Full University Professor, BOKU

Cristiana Boi , President,  European Membrane Society , Assistant Professor, DICAM

David Brindley , Chief Scientific Officer, Aegate ; Managing Partner, IP Asset Ventures ; Senior Research Fellow, University of Oxford

Dylan Jones , Principal Scientist, Genzyme

Hansjörg Hauser , Dept. of Scientific Strategy, Helmholtz Centre for Infection Research GmbH

Harald Bradl , Director & Head of Cell Culture Development, Boehringer Ingelheim

Helene Faustraup-Kildegaard , Senior Researcher and Co PI, Technical University of Denmark

Hitto Kaufmann , Global Vice President of Biopharmaceutical Development and Platform Innovation, Sanofi

Joachim Häfner , Senior Transfer Engineer, Boehringer Ingelheim

Jelena Ochs , Head of Business Unit, Fraunhofer Institute for Production Technology IPT

Kumar Dhanasekharan , Senior Director & Head, Biologics Process & Analytical Development, Amicus Therapeutics

Manuel J T Carrondo , Professor of Chemical & Biochemical Engineering, FCT-UNL, Vice-President, IBET

Marijke Wynants , MSAT Lead, Sanofi

Massimo Morbidelli , Professor of Chemical and Bio Engineering, ETH Zurich

Neils Koenig , Head of department "Production metrology", Fraunhofer Institute for Production Technology IPT

Nicolas Urbieta , USP Process Scientist, BST / BioRealization, Sanofi

Oliver Spadiut , Integrated Bioprocess Development, Chemical Engineering, TU Wien

Otto Wilhelm-Merten , Head of Applied Vectorology and Innovation group, Genethon

Paula Meleady , Associate Director, National Institute for Cellular Biotechnology

Representative from Sartorius

Sergey A. Piletsky , Professor of Bioanalytical Chemistry, Chemistry Department, College of Science & Engineering, University of Leicester

Tudor Arvinte , CEO, Therapeomic Inc. Basel , Professor, University of Geneva

Veronique Chotteau , Principal Investigator, Cell Technology Group, School of Biotechnology, KTH – Royal Institute of Technology

Representative from Sartorius


Cord Blood:

Alexander Platz  , MD, DKMS,   Cord Blood Bank 

Amnon Pelz , CEO, Taburit

André Gerth  , Chief Executive Officer,   Vita 34

Andre Gomes  , CEO,   Stemlab

Andrea Piccin  , Consultant Haematologist,   San Maurizio Regional Hospital

Beth Shaz  , Chief Medical Officer,   New York Blood Centre

Charis Ober , Founder, Save the Cord Foundation

Chiranya (Anjie) Prachaseri  , CEO, South East Asia,   Cryoviva

Colleen Delaney  , Founder and Chief Medical Officer, Nohla Therapeutics

Daniel Surbek  , Professor, Acting Chairman, Department of Gynaecology and Obstetrics,   University Hospital Bern

Elizabeth Shpall, Director, MD Anderson Cancer Center

Filippo Milano , Associate Director Cord Blood Transplantation, Fred Hutchinson Cancer Research Center

Glyn Stacey  , Director,   UK Stem Cell Bank

Gocha Shatirishvili  , Medical Director,   Geocord

Hector Mayani  , Head, Oncology Research Unit, IMSS National Medical Center,   Cordon Vital

Helen Papadaki  , Professor of Haematology, University of Crete, Head of the Department of Haematology,   Public Cord Blood Bank of Crete

Irene Martini  , Owner & Scientific Director,   SmartBank   ; CEO   Nanog International   ; Advisory Board Member,   Parent’s Guide to Cord Blood Foundation

Jaap Boeleans  , Haematology Consultant, Blood and Marrow Transplantation program,   UMC Utrecht

Jane Apperley  , Chair of the Department of Haematology,   Imperial College London

Joanne Kurtzberg  , Director,   Carolinas Cord Blood Bank  , Chief Scientific Officer,   Robertson Clinical & Translational Cell Therapy Program  , Director, Pediatric Blood and Marrow Transplant Program

Kate Falcon Girard, Director of Medical and Scientific Affairs, Viacord

Katy Rezvani , Director of Translational Research, MD Anderson Cancer Center

Kavita Raj   , Consultant Haematologist,   Guy's and St Thomas' Hospital

Kay Poulton PhD FRCPath , Consultant in Histocompatibility and Immunogenetics, Director, Transplantation Laboratory, Manchester Royal Infirmary, MFT

Lorenzo Beltrame , Researcher, University of Exeter

Mayur Abhaya , CEO, LifeCell

Moshe Israeli  , Director of Tissue Typing Laboratory,   Rabin Medical Centre

Kate Sneddon  , CEO,   Biovault

Lorenzo Beltrame  , Researcher, Department of Sociology and Social Research,   University of Exeter

Maria Craig   , Professor of Paediatric Endocrinology,   The Children's Hospital at Westmead

Marko Strbad   , CEO,   Biobanka

Mitchell Cairo   , Chief, Pediatric Hematology/Oncology & Stem Cell Transplantation,   New York Medical College

Warachaya Fongsarun  , Medical Director,   Thai StemLife

Husein Salem  , CEO,   Precious Cells Biobank

Rajeev Gupta  , Senior Lecturer, Haematology,   UCLH

Ronald De Lagrange , CEO, Macopharma

Sky Summers, Parent patient advocate

Salmaan Dalvi  , CEO,  Precious Cells Biobank 

Wolfgang Knirsch  , CEO,  Vita34

Yael Margolin , President and CEO, Gamida Cell


Precision Medicine

Aarno Palotie   , Group Leader,    Massachusetts General Hospital

Aaron Black   , Director of Informatics,    Inova

Alain Thierry   , Research Director,    INSERM 

Alastair Kent  , Ambassador,  Genetic Alliance UK 

Ana Alfirevic  , Reader in Pharmacology,  University of Liverpool

Ansar Jawaid   , Founder and Chief Executive Officer,    Precision Medicines 

Anthony Whetton    , Director, Stoller Biomarker Discovery Centre,    University of Manchester 

Brad Perkins    , Chief Medical Officer,    Human Longevity

Cecilia Lindskog Bergstrom    , Site Director, Human Protein Atlas,    Uppsala University

Charles Cox   , Head of Pharmacogenetics,   GSK

Christophe Le Tourneau    , Head of Phase I programme & Co-head of the Clinical Trial Unit,    Institut Curie 

Clare Turnbull,    Senior Researcher in Cancer Genomics,    Institute of Cancer Research  

David Pearce    , President,    Sanford Health

David Smith    , Professor,    Mayo Clinic           

David Fenstermacher   , Vice President, R&D Bioinformatics,   MedImmune

Dipak Kalra    , President,    EuroRec 

Enrico Heffler  , Assistant Professor in Respiratory Medicine; Personalised Medicine, Asthma & Allergy Unit,  Humanitas University (Milan, Italy) 

Evangelos Kiskinis  , Director Stem Cell Core Facility, Co-Director, Stem Cell and Regenerative Biology, Northwestern University,  Feinberg School of Medicine

Gil Alterovitz,    Assistant Professor,    Harvard/MIT  

Hakim Yadi , CEO,  NHSA

Helena Kilpinen  , Principal Investigator, Genetics and Genomic Medicine Programme,  UCL 

Jacqui Shaw    , Professor of Translational Cancer,    University of Leicester 

Jan Kuentzer    , Head of Data Science Application Services,    Roche

Jane Dunnage    , Patient and Public Involvement Lead,    Lupus UK

Janette Rawlinson    , Lay Member,    CRUK Stratified Medicine Programme 

Jay Goth    , Managing Member,    Forentis Fund 

Jean-Louis Mandel    , Professor of Human Genetics, College de France,    University of Strasbourg 

Jeffrey Barrett    , Vice President of Interdisciplinary Pharmacometrics Program and Head of Translational Informatics,    Sanofi

Jeff Skopek    , Lecturer in Medical Law, Ethics, and Policy,    University of Cambridge

Joni Rutter , Director of Scientific Programs,  National Institutes of Health

Juergin Eils    , Group Leader,    German Cancer Research Centre 

Julia Wilson    , Associate Director,    Wellcome Trust Sanger Institute 

Julien De Salaberry    , Managing Director,    The Asia HealthTech Connector 

Karen Harrison    , Support Services Manager,    ADL Life

Karina Bienfair  , Head, Global Genomics Policy, Process and Compliance,    MSD (Merck Research Laboratories)

Katherine Payne, Professor of Health Economics, Manchester Centre for Health Economics, The University of Manchester

Lizzie Tuckey , Director of Clinical Strategy,  Bupa

Louis Fiore    , C.S.P. Director of Bioinformatics,    Department of Veterans Association

Maria Chatzou    , Research Bioinformatics Engineer & President,    Innovation Forum Barcelona Centre for Genomic Regulation  
Marie-Claire Parker    , Business Development Manager,    Scottish Stratified Innovation Medical Center 

Mark Watson  , Head of Programmes, Molecular Medicine Ireland, Investigator, CÚRAM,  The SFI Centre for Research in Medical Devices

Mathew Woodwark  , Director of Research Bioinformatics,  MedImmune

Matthieu-P. Schapranow  , Programme Manager E-Health & Life Sciences,  Hasso Plattner Institute

Melina Kalofonou    , Postdoctoral Researcher,    Imperial College London 

Michael Kiebish  , Chief Precision Medicine Officer,  Berg Health

Nancy Krunic , Global Head, Future Precision Medicine,  Novartis

Nikole Kimes , Co-Founder and Vice President,  Siolta Therapeutics 

Noel Burtt , Program Manager,  Broad Institute

Pantelis Grorgiou    , Senior Lecturer,    Imperial College London 

Paul-Peter Tak    , Senior Vice President of Research and Development Pipeline, Chief Immunology Officer,    GSK 

Pedro Ballester  , Group Leader,  INSERM

Pierre Meulien  , Executive Director,  Innovative Medicines Initiative

Representative  Scottish Stratified Innovation Medical Center 

Ricardo Sabatini   , Co-founder, Chief Data Officer,   Orionis Biosciences

Rob Royea  , CEO,  Cyrcadia Health

Ron Przygodzkiy    , Director, Genomic Medicine Implementation,    Department of Veterans Association

Rosemary Barber    , Honorary Senior Research Fellow, Public Health,    University of Sheffield 

Sally John   , VP Genomics and Computational Biology,   Biogen

Sandosh Padmanabhan , Professor of Cardiovascular Genomics and Therapeutics,  University of Glasgow

Scott Robinson   , CSO,   Microquin

Seshandri Vasan    , Senior Business Development Manager, University of York,    Public Health England          

Shrikant Mane    , Director of Center for Genome Analysis,    Yale School of Medicine

Stephen Deitcher    , Chief Executive Officer,    Medeor Therapeutics

Stephen Thomas    , Patient Involvement Coach,    Cancer Research UK

Sudhakaran Prabakaran  , Lecturer, Department of Genetics,    Cambridge University 

Sue Hill    , Chief Scientific Officer,    NHS

Thomas Hach   , Director Healthcare Systems,   Novartis International AG

Tom Kaier  , BHF Clinical Research Fellow, Department of Cardiology,  St Thomas’ Hospital

Tony Freemont  , Professor of Osteoarticular Pathology,    Manchester University 

Vivienne Parry , Head of Engagement,  Genomics England

Wildon Farwell  , Senior Medical Director, Clinical Development,  Biogenv



Artificial Intelligence in Healthcare:

Bissan Al Lazikani   , Head of Data Science,   Institute of Cancer Research

Brandon Allgood   , CEO,   Numerate

Brian Goldman   , Research Fellow,   Vertex Pharmaceuticals

Cliona Molony   , Head of Computational Biomedicine,   Pfizer 

Daniel Ray  , Director of Data,  NHS Digital

Dmitry Kaminskiy  , Founding Partner,  Deep Knowledge Ventures

Ed Addison   , Chairman and Chief Executive Officer,   Cloud Pharmaceuticals

Eerke Boiten   , Professor of Cyber Security,   De Montfort University

Enrico Ferrero   , Scientific Leader, Computational Biology & Stats,   GSK

Farooq Abbasi  , Associate Partner,  Mosaic Ventures 

Hazem Danny Al-Nakib  , Partner,  Deep Knowledge Ventures

Ian Abbs  , Chief Medical Officer,  Guy’s & St Thomas’ NHS Foundation Trust

Iain Hennessey , Clinical Director of Innovation,  Alder Hey Children’s Hospital

Jade Reed  , Funding Manager,  Entrepreneur First

Juergen Hammer   , Global Head, Data Science,   Roche

Jun Dong   , Director, Business Partner for Global Regulatory Affairs and Development, Information Technology & Solutions,   Sanofi

Mahiben Maruthappu   , Co-founder, NHS Innovation Accelerator,   NHS

Milind Kamkolar   , CDO,   Sanofi

Patrick Keohane   , CMO,   Benevolent AI

Pau Herrero Vinas   , Post Doc,   Imperial College London

Rangaprasad Sarangarajan   , CSO,   Berg

Ron Alfa   , VP of Product Discovery ,   Recursion Pharmaceuticals

Sam Smith   , Co-ordinator,   MedConfidential

Saman Farid  , Founder,  CometLabs

Suzanne Ashman  , Partner,  LocalGlobe

Thomas Keller  , Fellow and Senior Director,  Prediction Medicine and Data Science, GSK 

William Paiva   , Executive,   Oklahoma State University

Zachary Yerushalmi  , Principal,  Oxford Sciences

Laura Ferraiuolo   , Lecturer, Translational Neurobiology,   The University of Sheffield

Jim Fackler   , Associate Professor,   John Hopkins School of Medicine

Tim Guilliams   , CEO,   Healx

Mike McCormick   , Principal,   Deep Venture Capital  Ziad Obermeyer   , Assistant Professor of Emergency Medicine,   Harvard Medical School

Niels Peek   , Director,   Greater Manchester Connected Health City 

Gil Alterevoz   , Assistant Professor,   Harvard/MIT 

Nivan Narain   , Co-founder and CEO,   Berg 

John Fox   , Professor of Medical Informatics,   University of Oxford

Senior Representative,  Viz.AI

Representative,   ICO


To exhibit or sponsor call Erica Baeta on
+44(0) 207 092 1152 or email erica.baeta@terrapinn.com








The World Advanced Therapies & Regenerative Medicine Congress is two events: a world-class conference where hundreds of pharma, biotech and academia leaders from around the planet meet and a fantastic exhibition. To visit the show is free. There is, naturally, a registration fee to attend the conference.

phone: +44 (0)207 092 1237